Home Cart Sign in  
Chemical Structure| 501692-44-0 Chemical Structure| 501692-44-0

Structure of Odevixibat
CAS No.: 501692-44-0

Chemical Structure| 501692-44-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Odevixibat (A4250) is an effective selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT). Odevixibat alleviates bile duct damage and cholestasis in mouse models and can be used for research on primary biliary cirrhosis.

Synonyms: A4250

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Odevixibat

CAS No. :501692-44-0
Formula : C37H48N4O8S2
M.W : 740.93
SMILES Code : CC[C@H](NC([C@H](NC(COC1=C(SC)C=C(C2=C1)N(C3=CC=CC=C3)CC(CCCC)(CCCC)NS2(=O)=O)=O)C4=CC=C(O)C=C4)=O)C(O)=O
Synonyms :
A4250
MDL No. :MFCD32710220

Safety of Odevixibat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02630875 Pediatric Cholestasis PHASE2 COMPLETED 2017-03-17 Department of Pediatric and Ad... More >>olescent Medicine Rigshospitalet, Copenhagen, Denmark|Pediatric Hepatology and Liver Transplantation, University Hospitals of Paris-Sud, Paris, Orsay, France|Department of Pediatric Gastroenterology Hepatology-Nutrition, Necker-Enfants maladies hospital, Paris, France|Pediatric Gastroenterology and Hepatology, Pediatric Surgery, Hannover, Hannover, Germany|Gastroenterology/Hepatology, University Hospital for Children and Adolescents, Tuebingen, Germany|Henrik Arnell, Stockholm, 17176, Sweden|King's College Hospital NHS Foundation Trust, London, United Kingdom Less <<
NCT04483531 Progressive Familial Intrahepa... More >>tic Cholestasis Less << APPROVED_FOR_MARKETING - Albireo Pharma Inc., Boston, M... More >>assachusetts, 02109, United States Less <<
NCT05035030 Alagille Syndrome PHASE3 RECRUITING 2026-04-09 UCSF, San Francisco, Californi... More >>a, 94158, United States|University of California San Francisco (UCSF), San Francisco, California, 94158, United States|Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Children's Mercy Hospital and Clinics, Kansas City, Missouri, 64018, United States|The Childrens Hospital at Montefiore Albert Einstein School of Medicine, Bronx, New York, 10467, United States|Hassenfeld Children's Hospital at NYU Langone, New York, New York, 10016, United States|Texas Liver Institute, San Antonio, Texas, 78215, United States|Cliniques Universitaires Saint-Luc Bruxelles, Bruxelles, 1200, Belgium|H?pital Femme Mère Enfant de Lyon, Bron, 69677, France|Antenne pediatrique du CIC-Hopital Jeanne De Flandre, Lille, France|Hopital Necker Enfants Malades, Paris, 75015, France|Charité - Universit?tsmedizin Berlin, Berlin, 13353, Germany|Medizinische Hochschul, Hannover, 30625, Germany|Universitatsklinik fur Kinder-und Jugendmedizin Tubingen, Tübingen, 72076, Germany|AOU Meyer, Florence, Italy|Azienda Ospedale University, Padova, 35128, Italy|Ospedale Pediatrico Bambino Gesu, Rome, 00165, Italy|University of Malaya Medical Center, Kuala Lumpur, 59100, Malaysia|University of Malaya Medical Centre, Pantai, Malaysia|Universitair Medisch Centrum Groningen, Groningen, 9713 GZ, Netherlands|University Medical Center, Utrecht, Netherlands|Instytut Pomnik-Centrum Zdrowia Dzieck, Warszawa, 04-730, Poland|Istanbul University Istanbul Medical Faculty Hospital, Istanbul, Turkey|King's College Hospital NHS Foundation Trust King's College Hospital Paediatric Research, London, SE5 9RS, United Kingdom Less <<
NCT03608319 Healthy Volunteers PHASE1 COMPLETED 2018-08-18 Celerion, Lincoln, Nebraska, 6... More >>8502, United States Less <<
NCT02360852 Biliary Cirrhosis, Primary PHASE2 TERMINATED 2025-10-16 Sahlgrenska Academy, G?teborg,... More >> Sweden Less <<
NCT05426733 Biliary Atresia PHASE3 ENROLLING_BY_INVITATION 2028-08-31 Children's Hospital Colorado, ... More >>Aurora, Colorado, 80045, United States|Children's Healhcare of Atlanta- Emory University school of medicine, Atlanta, Georgia, 30322, United States|Indiana University school of Medicine, Indianapolis, Indiana, 46202, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Children's Mercy Hospital and Clinics, Kansas City, Missouri, 64108, United States|The Childrens Hospital at Montefiore Albert Einstein School of Medicine, Bronx, New York, 10467, United States|Hassenfeld Children's Hospital at NYU Langone, New York, New York, 10016, United States|Columbia University Medical Center New York Presbyterian Morgan Stanley-Komansky Childrens Hospital, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Royal Children's Hospital, Parkville, 3052, Australia|CHU Sainte-Justine, Montréal, Canada|The Hospital for Sick Children, Toronto, Canada|Guangzhou Women And Childrens Medical Center, Guangdong, China|Children's Hospital of Fudan University, Shanghai, China|Bicêtre Hospital, Le Kremlin-Bicêtre, France|Charité - Universit?tsmedizin Berlin, Berlin, Germany|University Children′s Hospital Tuebingen, Tuebingen, Germany|ASST Papa Giovanni XXIII, Bergamo, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Seoul National University Childrens Hospital, Seoul, Korea, Republic of|Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia|University Malaya Medical Centre, Kuala Lumpur, 59100, Malaysia|University Medical Center Groningen, Groningen, Netherlands|Starship Child Health, Te Whatu Ora - Health New Zealand, Auckland, 1023, New Zealand|Instytut Pomnik-Centrum Zdrowia Dziecka, Warsaw, Poland|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hacettepe ?hsan Do?ramac? Children's Hospital, Ankara, Turkey|Akdeniz University Medical Faculty, Antalya, Turkey|Istanbul University Istanbul Medical Faculty Hospital, Istanbul, Turkey Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.35mL

0.27mL

0.13mL

6.75mL

1.35mL

0.67mL

13.50mL

2.70mL

1.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories